vs
Cytek Biosciences, Inc.（CTKB）与LandBridge Co LLC（LB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是LandBridge Co LLC的1.2倍（$62.1M vs $51.0M），LandBridge Co LLC净利率更高（35.0% vs -70.9%，领先106.0%），LandBridge Co LLC同比增速更快（16.0% vs 8.1%），LandBridge Co LLC自由现金流更多（$40.9M vs $-1.8M），过去两年LandBridge Co LLC的营收复合增速更高（40.2% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
CTKB vs LB — 直观对比
营收规模更大
CTKB
是对方的1.2倍
$51.0M
营收增速更快
LB
高出7.9%
8.1%
净利率更高
LB
高出106.0%
-70.9%
自由现金流更多
LB
多$42.7M
$-1.8M
两年增速更快
LB
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $51.0M |
| 净利润 | $-44.1M | $17.9M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 57.2% |
| 净利率 | -70.9% | 35.0% |
| 营收同比 | 8.1% | 16.0% |
| 净利润同比 | -557.1% | 15.6% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBLB
| Q1 26 | — | $51.0M | ||
| Q4 25 | $62.1M | $56.8M | ||
| Q3 25 | $52.3M | $50.8M | ||
| Q2 25 | $45.6M | $47.5M | ||
| Q1 25 | $41.5M | $44.0M | ||
| Q4 24 | $57.5M | $36.5M | ||
| Q3 24 | $51.5M | $28.5M | ||
| Q2 24 | $46.6M | $26.0M |
净利润CTKBLB
| Q1 26 | — | $17.9M | ||
| Q4 25 | $-44.1M | $8.1M | ||
| Q3 25 | $-5.5M | $8.1M | ||
| Q2 25 | $-5.6M | $7.5M | ||
| Q1 25 | $-11.4M | $6.5M | ||
| Q4 24 | $9.6M | $49.3M | ||
| Q3 24 | $941.0K | $2.7M | ||
| Q2 24 | $-10.4M | $-57.7M |
毛利率CTKBLB
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
营业利润率CTKBLB
| Q1 26 | — | 57.2% | ||
| Q4 25 | -9.0% | 60.0% | ||
| Q3 25 | -17.6% | 60.8% | ||
| Q2 25 | -23.3% | 60.0% | ||
| Q1 25 | -36.1% | 57.0% | ||
| Q4 24 | 5.2% | 49.4% | ||
| Q3 24 | -8.2% | 11.2% | ||
| Q2 24 | -18.3% | -197.4% |
净利率CTKBLB
| Q1 26 | — | 35.0% | ||
| Q4 25 | -70.9% | 14.2% | ||
| Q3 25 | -10.5% | 15.9% | ||
| Q2 25 | -12.2% | 15.8% | ||
| Q1 25 | -27.5% | 14.7% | ||
| Q4 24 | 16.8% | 135.2% | ||
| Q3 24 | 1.8% | 9.3% | ||
| Q2 24 | -22.4% | -222.1% |
每股收益（稀释后）CTKBLB
| Q1 26 | — | — | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $29.7M |
| 总债务越低越好 | — | $433.0K |
| 股东权益账面价值 | $341.7M | — |
| 总资产 | $461.5M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBLB
| Q1 26 | — | $29.7M | ||
| Q4 25 | $90.9M | $30.7M | ||
| Q3 25 | $93.3M | $28.3M | ||
| Q2 25 | $75.5M | $20.3M | ||
| Q1 25 | $95.3M | $14.9M | ||
| Q4 24 | $98.7M | $37.0M | ||
| Q3 24 | $162.3M | $14.4M | ||
| Q2 24 | $177.9M | $24.6M |
总债务CTKBLB
| Q1 26 | — | $433.0K | ||
| Q4 25 | — | $570.7M | ||
| Q3 25 | — | $366.1M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $375.5M | ||
| Q4 24 | — | $385.5M | ||
| Q3 24 | — | $242.4M | ||
| Q2 24 | — | $360.8M |
股东权益CTKBLB
| Q1 26 | — | — | ||
| Q4 25 | $341.7M | $340.3M | ||
| Q3 25 | $378.6M | $272.0M | ||
| Q2 25 | $377.6M | $266.4M | ||
| Q1 25 | $379.6M | $217.0M | ||
| Q4 24 | $395.7M | $211.8M | ||
| Q3 24 | $385.5M | $97.2M | ||
| Q2 24 | $389.1M | $296.4M |
总资产CTKBLB
| Q1 26 | — | $1.4B | ||
| Q4 25 | $461.5M | $1.4B | ||
| Q3 25 | $494.9M | $1.1B | ||
| Q2 25 | $493.3M | $1.1B | ||
| Q1 25 | $482.6M | $1.0B | ||
| Q4 24 | $499.5M | $1.0B | ||
| Q3 24 | $491.2M | $689.9M | ||
| Q2 24 | $483.7M | $710.5M |
负债/权益比CTKBLB
| Q1 26 | — | — | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $41.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $40.9M |
| 自由现金流率自由现金流/营收 | -2.9% | 80.3% |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | 2.30× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $232.8M |
8季度趋势，按日历期对齐
经营现金流CTKBLB
| Q1 26 | — | $41.1M | ||
| Q4 25 | $-771.0K | $126.3M | ||
| Q3 25 | $-3.9M | $34.9M | ||
| Q2 25 | $108.0K | $37.3M | ||
| Q1 25 | $-125.0K | $15.9M | ||
| Q4 24 | $2.0M | $67.6M | ||
| Q3 24 | $13.2M | $7.5M | ||
| Q2 24 | $6.2M | $16.0M |
自由现金流CTKBLB
| Q1 26 | — | $40.9M | ||
| Q4 25 | $-1.8M | $122.0M | ||
| Q3 25 | $-4.6M | $33.7M | ||
| Q2 25 | $-1.5M | $36.1M | ||
| Q1 25 | $-974.0K | $15.8M | ||
| Q4 24 | $1.1M | $66.7M | ||
| Q3 24 | $12.2M | $7.1M | ||
| Q2 24 | $5.2M | $15.7M |
自由现金流率CTKBLB
| Q1 26 | — | 80.3% | ||
| Q4 25 | -2.9% | 214.9% | ||
| Q3 25 | -8.7% | 66.3% | ||
| Q2 25 | -3.2% | 75.9% | ||
| Q1 25 | -2.3% | 36.0% | ||
| Q4 24 | 1.9% | 182.6% | ||
| Q3 24 | 23.7% | 25.1% | ||
| Q2 24 | 11.0% | 60.4% |
资本支出强度CTKBLB
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 7.5% | ||
| Q3 25 | 1.3% | 2.3% | ||
| Q2 25 | 3.5% | 2.6% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 2.0% | 1.1% | ||
| Q2 24 | 2.3% | 1.4% |
现金转化率CTKBLB
| Q1 26 | — | 2.30× | ||
| Q4 25 | — | 15.68× | ||
| Q3 25 | — | 4.31× | ||
| Q2 25 | — | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | 0.21× | 1.37× | ||
| Q3 24 | 14.05× | 2.80× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
LB
| Other | $14.2M | 28% |
| Easements and other surface-related revenues | $11.6M | 23% |
| Surface use royalties - related party | $11.0M | 22% |
| Resource sales | $5.2M | 10% |
| Resource royalties | $4.3M | 8% |
| Easements and other surface-related revenues - related party | $3.2M | 6% |
| Resource royalties - related party | $1.3M | 2% |
| Resource sales - related party | $205.0K | 0% |
